https://www.selleckchem.com/pr....oducts/pqr309-bimira
BACKGROUND Opioid consumption in North America has risen to alarming levels and represents a potentially modifiable risk factor in perioperative management. Chronic pain and obesity are commonly associated and bariatric surgery remains the most effective intervention for weight loss in morbidly obese patients. OBJECTIVES To understand how preoperative opioid use impacts surgical outcomes in patients undergoing bariatric surgery. SETTING The Ontario Bariatric Registry. METHODS Data collected in the Ontario Bariatric Registry b